对固体瘤中TCR-T细胞疗法的新见解:优化采用免疫疗法
Weihuan Shao1,2, Yiran Yao1,2, Ludi Yang1,2
1Department of Ophthalmology, Ninth People's Hospital, Shanghai JiaoTong University School of Medicine, 639 Zhi Zao Ju Road, Shanghai Ninth People's Hospital, Shanghai, 200011, People's Republic of China.
Experimental hematology & oncology
|April 3, 2024
概括
通过向细胞内抗原,TCR-T细胞疗法对固体瘤具有前景. 本综述涵盖了抗原识别,TCR优化,以及从实验室到诊所的旅程,以加强癌症治疗.
科学领域:
- 免疫治疗是一种免疫疗法.
- 在瘤学瘤学.
- 细胞疗法细胞疗法
背景情况:
- 采用免疫疗法,特别是CAR T细胞,已经推进了血液癌症治疗.
- 经过T细胞受体 (TCR) 工程的T细胞正在出现,用于固体瘤,识别细胞内抗原.
- TCR-T细胞为耐火固体瘤提供了潜在的潜力,但在持久有效性方面面临着挑战.
研究的目的:
- 审查用于TCR-T细胞治疗的抗原鉴定和TCR优化.
- 总结TCR-T细胞疗法的过程,从实验室研究到临床应用.
- 探索未来的策略,以改善固体瘤中TCR-T细胞治疗的疗效.
主要方法:
- 关于瘤抗原和TCR工程的当前文献的综述.
- 对TCR-T细胞疗法开发和临床转化工作流程的分析.
- 讨论组合疗法和新型TCR-T细胞产品.
主要成果:
- 针对TCR向的瘤抗原的识别和查.
- 优化TCRs以提高亲和力和信号传导.
- 对TCR-T细胞疗法的转化途径的总结.
结论:
- TCR-T细胞疗法在治疗固体瘤方面具有显著的潜力.
- 需要进一步的研究来克服挑战,并确保持久的治疗效果.
- 组合策略和先进的TCR-T细胞产品可以改善临床结果.
相关概念视频
Tumor Immunotherapy
523
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
523
T Cell Activation and Clonal Selection
721
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
721
Cytotoxic T Cells-mediated Immune Response
907
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
907


